Guanhao Biotech Co.,Ltd. (300238.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
Sector
Healthcare
Industry
Biotechnology
Employees
535
First IPO Date
July 06, 2011
| Name | Title | Pay | Year Born |
| Guofeng Xu | Chief Technology Officer | 0 | N/A |
| Feng Zhao | General Manager | 0 | 1978 |
| Huaixin Hou | Deputy General Manager | 0 | 1968 |
| Weikun Zhang | Deputy General Manager | 0 | 1986 |
| Xianggui Lin | Deputy General Manager | 0 | 1983 |
| Zhen You | Deputy General Manager | 0 | 1981 |
| Ruofeng Yi | Chief Financial Officer & Accounting Supervisor | 0 | 1977 |
| Xu Qingrong | Deputy GM & Secretary | 0 | 1981 |
| Junhui Zhao | Executive Vice President | 0 | 1976 |
Guanhao Biotech Co.,Ltd. is a Chinese enterprise dedicated to the research, production, and marketing of regenerative medicine solutions. Its product portfolio encompasses NormalGEN, a biological dura repair patch crafted from animal tissue, and GrandNeuro, an artificial alternative for dura restoration. For broader surgical applications, the company offers ThormalGEN, another biological surgical patch also derived from animal tissue. DermalGEN, an animal tissue-based wound dressing, is designed for treating burns, scalds, and skin injuries resulting from loss or trauma. Additionally, Guanhao Biotech markets the IREAL breast patch. The company was established in 1999 and is headquartered in Guangzhou, China.